Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Authors
Amitha Domalpally 1 , Qing Pan 2 , Emily Y Chew 3
Affiliations
1 Wisconsin Reading Center, Department of Ophthalmology, University of Wisconsin School of Medicine and Public and Health, Madison.
2 Department of Statistics, George Washington University, Washington, DC.
3 Division of Epidemiology and Clinical Applications, Clinical Trials Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Dr. Emily Chew (CRADA Partner)
July 2023
NIH/NEI
https://pubmed.ncbi.nlm.nih.gov/37227711/
Getting the docs squared away.
Again. Hans is not charged nor arrested. So will see how this unfolds
pdgood if Hans is charged or arrested then I’ll believe you.
But at this point it looks like he may be cleaning up.
A CEO update on what steps remain to file the FDA IND would be awesome right now!
Let them complete their filing to be current and name change.
I don’t accept the current BoD people consisting of accomplished execs and a lawyer to participate in criminal entities.
Don’t count them out.
Shares and shell remain intact or dissolved. Unfamiliar with this situation.
Or nothing has changed at this time?
So now what?
once the significant steps are complete you’ll get your 3 cents and we will celebrate the increase and you gone forever
How would you define intelligent? Degrees, experience, network, perceptions?
iRobot is the seller/flipper
I’ve only noticed that after iRobot sells then iRobot comes back on to invite pumpers so it goes back up and then like clock work iRobot sells and then begins to moan and groan as a cover
Pdgood probably lost a girlfriend to Hans
Or pdgood is an old jaded girlfriend of Hans
Never seen so much hate before
Apellis would not be a bad partner to have and acquire CUBT now! $0.40 per share sounds good to me! Might be good for both.
https://www.nobelpharma.co.jp/en/
Would be interesting if we do business with this company.
Correct! Basic stuff here… lol
Trying to help out Robo
Exactly … we are moving forward
Your referring to excipients and diluents because the chemical structure of metformin is metformin and the chemical structure of the substrate hydrochloride is hydrochloride
Hans very active on LinkedIn these last weeks/months even tagging Saphire Risk Advisory who is on Board for Dazed
Need OTC paperwork issue/delay completed.
https://www.linkedin.com/posts/hansenriquez_history-of-medical-marijuana-in-texas-activity-6900040910323671040-KhiN
Besides monitoring the FDA and Clinical Trials website it would be ideal to monitor the Japan equivalent of the FDA to see if anything comes across their portals.
https://www.pmda.go.jp/english/
It’s looking promising. Dr. Bharti promoted at NEI and Dr. Emily Chew our investigator at NIH/NEI received an award. Legit Experts!
As real as can be… load towards 2024. Bring on an IND application then a deal.
This just in: #NEI's Emily Chew is the recipient of the 2024 Proctor Medal!
— NEI (@NatEyeInstitute) April 25, 2023
Established in 1949 as a memorial to Dr. Francis I. Proctor, this award honors outstanding research in the basic or clinical sciences as applied to ophthalmology.
Congratulations, Emily! pic.twitter.com/rVM7lLjqjo
Writing in black and white! It’s happening.
Patent for USA and International rights. Japan subsidiary. Another company acquisition for same/similar indications by Astellas (Japanese company) for $5 billion.
I’ll take $500 million!
https://www.modernretina.com/view/patent-filed-by-curative-biotechnology-with-international-consideration
CUBT has potential. Japan and ophthalmology indications.
https://www.prnewswire.com/news-releases/astellas-enters-into-definitive-agreement-to-acquire-iveric-bio-301811623.html
Anyone hear about a Japanese company acquiring an ophthalmology company for >$5 billion for indication of GA / secondary to AMD and also Stargardts?
CUBT might be on to something… laying the groundwork for a hopeful opportunity
Open the store and clean up that paper trail
That #5?
Here it is!! pic.twitter.com/kubqwhqTEY
— the 1 & Only HANS (@The1OnlyHans) June 12, 2023
Bottom of the recent PR. Coming this year…2023. Anticipating the second wave … hopeful.
“The first therapeutic to be developed on this platform is a Metformin Reformulation targeting the treatment of intermediate and late-stage Age-Related Macular Degeneration (AMD) disease with the goal of being in the clinic in 2023 for a first in human trial of its metformin-based eye drop. The trial will be conducted under a Cooperative Research and Development Agreement (CRADA) with the NEI.”
Seems likely that those who add here will ride the wave to > $0.10
From 2016??? Irrelevant
I don’t have Twitter. If you do ask him where the 5 mil shares are lol
So silly… it’s all in the past.
Can’t take you seriously pdgood
Going to buy 5MM shares in the AM. let’s get this back where it belongs.
— Original CriYolo (@MaduroCriollo) March 29, 2023
Pdgood got a shout out!!! Lmao
Hans says gtfo lol… you loser, he ain’t worried about you
Gotta a W today. The legal case: Epidemiologic Solution Corporation, Expanse Enterprises, LLC; & Randy Goulding
— the 1 & Only HANS (@The1OnlyHans) March 28, 2023
V.
MedX Holdings Inc.,
Case No. 2020 CH 05699
was dismissed. $medh #lfg Feels good to get a win ! Tell pdgood #gtfo here!! Picture of my homemade salsa for fun! pic.twitter.com/RzDiMKNomW
Are you okay? Lol
Okay so now pdgood is saying Hans was apart of the two banks that failed. Lol
No worries!
Albuquerque Lazydaze location has this phone number listed 737-200-0662.
Looks like an Austin area code.
Watching it closely. Google it for yourself to see